This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
At DrugBank, we’re dedicated to empowering pharmaceutical researchers with data that drives impactful results. Your Need for Accessible, High-Quality Data—Solved Pharmaceutical research and healthcare innovation demand timely access to comprehensive, up-to-date data. In fact, poor data quality is estimated to cost U.S.
However, due to its unique biology and structural complexity, PAR2 has proven notoriously difficult for the pharmaceutical industry to effectively target. DT-9046 is currently progressing through pre-IND studies, supported by a robust data package, including head-to-head benchmarks and strong patent protection.
By accelerating timelines, anticipating challenges and alleviating bottlenecks, pharmaceutical companies and combined CDMO and CRO partners together can help ensure those potential treatments reach the patients who need them as efficiently as possible.
Meeting the Growing Demand for High-Concentration Biologics High-concentration biologics—generally defined as injectable formulations with protein concentrations exceeding 100 mg/mL—have become a strategic priority for many pharmaceutical developers. WuXiHigh™ 2.0: Pushing the Boundaries With WuXiHigh™ 2.0,
By moving to tablets, BeOne estimates a reduction in bottle size by approximately 70%, which not only decreases plastic use but also facilitates more efficient packaging and transportation. These sustainability considerations align with growing global demand for environmentally responsible pharmaceutical manufacturing and distribution.
securing a funding package of up to $2 billion. Rather than diluting ownership or yielding developmental control to a larger pharmaceutical partner, Revolution Medicines is leveraging this funding arrangement to maintain autonomy over its research, development, and eventual commercialization efforts.
With a deep understanding of the industry’s complexities and the evolving market needs, he has been instrumental in providing innovative solutions for both biotech startups and large pharmaceutical companies. Each stage must adhere to strict quality and regulatory standards, even before considering fill-finish and packaging.
2] [3] Vamorolone is a novel and fully synthetic glucocorticoid developed by Santhera Pharmaceuticals. 10] Society and culture Legal status Santhera Pharmaceuticals signed an agreement with Catalyst Pharmaceuticals for the North American commercialization of vamorolone in July 2023. [20] Retrieved 14 March 2024. 7 November 2023.
Key components of the CMC section The CMC section of an NDA contains detailed information on the following aspects of the investigational drug: Drug substance or active pharmaceutical ingredient (API). The objective is to demonstrate that the manufacturing process consistently produces a product that meets all predefined specifications.
The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation. Take the time to clearly define your technical needs, from drug substance manufacturing to packaging requirements. How can you ensure your CDMO is up to scratch?
To scale-up manufacturing, Cohn asked around and was put in touch with Victor Conquest, a bright technical executive at Armour Laboratories, a pharmaceutical manufacturer in Chicago. With the construction of the pilot plant, Cohn built a scientific environment at Harvard that mimicked commercial pharmaceutical factories in one fell swoop.
But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.
PCI helps biopharmaceutical companies manufacture and package drug products used in clinical trials as well as commercially. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. By Jonathan Gardner • Sept. By Jonathan Gardner • Sept.
The Unsung Heroes of Generic Drugs: The Importance of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the behind-the-scenes efforts that ensure the quality and safety of the medications we rely on.
Generic drugs are pharmaceutical products that contain the same active ingredients as their brand-name counterparts. Understanding Generic Drugs: The Basics Before diving into educational strategies, let’s refresh our understanding of generic drugs and their importance in healthcare. What Are Generic Drugs?
Navigating the Complex World of Drug Patents: A Comprehensive Strategy is Key As a pharmaceutical professional, you know that developing new medications is a costly and time-consuming process. In today's highly competitive pharmaceutical landscape, it's essential to stay ahead of the curve when it comes to patent management.
My goal is not only to tell the story of a pharmaceutical staple but to share what my decades-long work in evidence synthesis in epidemiology has taught me about researching scientific history. In this article, Eichengrün stated that he was appointed, in 1895, to establish and manage a pharmaceutical laboratory at Bayer.
The generic drug approval process is a complex, multi-step journey that involves several stakeholders, including pharmaceutical companies, regulatory agencies, and healthcare professionals. The journey to approval is often shrouded in mystery, but it's a crucial process that affects millions of people worldwide.
Detailed numbers are provided by Genuine in the slides and the medication package insert. [14] Common (> 1%) side effects include nausea, elevated blood lipids, fever, insomnia, tiredness, and diarrhea. 17] Azvudine is toxic to the reproductive system of rats and rabbit. . 98 : 379–386. doi : 10.1016/j.jpba.2014.06.019. 2014.06.019.
Through a series of exclusive interviews and a survey of industry insiders, Connect in Pharma names the top pharmaceutical and manufacturing-related trends of 2023
Technology gurus, consultancy experts and motivational speakers from a wide range of industries are calling for a new, modern era of pharmaceuticalpackaging and manufacturing that utilises high-tech and innovative thinking from other industries.
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies.
In clinical research, the role of drug packaging systems cannot be overlooked. Industry guidelines require biopharmaceutical and biotechnology companies to test their pharmaceuticalpackaging systems, as the systems often experience prolonged and intimate contact with drug products, drug substances and intermediates.
Sildenafil, Trazodone Tablets Recalled After Being Packaged Together. 10, 2020 — Sildenafil and trazodone tablets have been recalled by pharmaceutical distributor AvKARE because the drugs were “inadvertently packaged together” when they were bottled by a third-party vendor, according to the company.
In the lead up to the inaugural launch of Connect In Pharma, co-founder Wilfried Phipps provides insight into what visitors can expect at this new annual event designed to help shape the future of pharmaceuticalpackaging and manufacturing projects
On April 26, 2023, the European Commission proposed a new package of pharmaceutical legislation 1 to revise many of the currently applicable Regulations.
Environmental Impacts of Traditional Pharmaceutical Production Traditional pharmaceutical manufacturing is complex, with each phase contributing to environmental degradation. The extraction and synthesis of active pharmaceutical ingredients (API) utilize vast amounts of water and energy.
The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to outsource various stages of drug development and manufacturing. This includes drug substance and drug product development, clinical trial logistics, product labeling, supply chain management, commercial packaging, and more.
Commission unveils “one substance, one assessment” reform package The Commission has long aspired to realize its one substance, one assessment concept in the EU’s chemical regulatory regime. Data from pharmaceutical legislation is not included by default, though some specifically named pharma data relating to chemicals will be encompassed.
This joint webinar presentation by West and Groninger, explores the unique challenges of Cell and Gene Therapies, mRNA LNP therapeutics particularly regarding cold storage requirements and their impact on packaging solutions. Click here to login. Listing Image WestPharma_ListingLogo_250x190.png On Demand Start Date Wed, 02/12/2025 - 11:00
Innovations in aseptic processing for container closure systems dwunderlin Fri, 01/03/2025 - 14:26 Wed, 02/12/2025 - 10:00 Resource Type Webinar Jim Thompson Julian Petersen Duration 60 Minutes The pharmaceutical landscape is shifting from blockbuster drugs to personalized treatments, driving the need for innovative container closure systems.
Together with Ray Kamalika, a research bioinformatician at OMass Therapeutics, he developed Otargen , an R package offering a suite of functions to facilitate the retrieval and analysis of Open Targets Genetics data, including specialised plotting functions to help visualise the information. Have you used Otargen?
They provide pharmaceutical companies with the expertise and infrastructure needed to overcome technical, logistical and regulatory hurdles, ensuring efficient development, high-quality standards and timely market entry. By partnering with CDMOs, pharmaceutical companies can share the risks associated with ADC development and manufacturing.
The vote is in: The European Parliament has adopted the compromise pharmaceutical legislation This week, the European Parliament voted to adopt the compromise texts of both the revised pharmaceutical directive and regulation presented by Parliament’s health committee in March 2024. has a strong voice in the world. citizens; 2.
Just over a month ago, the European Commission released its proposal for the new pharmaceutical directive and regulation. What will the orphan drug market exclusivity haircut mean for industry?
The pharmaceutical industry is undergoing a major shift towards the development of breakthrough medicines and advanced therapies. Packaging is typically the patient’s first interaction with a product, and it is critical for communicating safety and benefit-risk information.
West Pharmaceutical Services (West) and Cytiva have teamed up to offer innovative and versatile fill finish solutions to efficiently meet the unique demands of advanced pharmaceutical applications. In this webinar, you will learn about: The challenges and risks related to the packaging and filling of high-value drug products.
If we look at the pharmaceutical industry’s discovery and development success rate over the last 20 to 30 years, it has not improved, staying stubbornly at around 10 percent. With support from pharmaceutical companies, ultimately, the answer to this question should be yes. Will systems like the NHS be able to deliver it?
Even though R as a programming language is constantly growing in popularity in the pharmaceutical industry, it is still quite unpopular to use R in the preliminary stages of research like importing data from different sources, tidying it, calculating new variables in datasets and making other amendments available in SAS data steps.
The pharmaceutical industry is exploring alternatives such as oral formulations, sublingual dissolvables, and transdermal methods to improve sustainability and patient convenience, though scientific hurdles like bioavailability remain.
There has been an unprecedented expansion of different types of pharmaceutical therapies, as well as a change in the overall approach to health care. PPD ® Laboratory services are backed by a proven track record with over three decades of experience providing CMC pharmaceutical testing.
” Sildenafil and T razodone T ablets Recalled After Being Packaged Together. Sildenafil and trazodone tablets have been recalled by pharmaceutical distributor AvKare because the drugs were “inadvertently packaged together” when they were bottled by a third-party vendor, according to the company.
Then, in 1997, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) formed the ICH M8 Expert Working Group/Implementation Working Group (EWG/IWG). Sponsors should prepare by reviewing implementation packages from the ICH and applicable regions. Implementation Package v1.5
Teva is donating medicines valued at over $11M, for acute therapies in support of Ukrainian refugees The donations include over 1 million packages of antibiotics and other essential medicines as well as hygienic products for Ukrainian infants and children. Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content